About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The VHIR Infectious Diseases research group is made up of medical professionals, with healthcare and clinical or basic translational research activities; of Biomedicine dedicated to basic research; and Nursing, with activities to support clinical research.
The group's lines of research are mainly focused on four areas:
Infections related to immunosuppression. Includes infectious diseases related to immunocompromised patients, solid organ or hematopoietic stem cell transplant recipients and recipients of biological therapies.
Sexually transmitted diseases, including HIV infection and other highly prevalent infections in our country (syphilis, gonorrhea, lymphogranuloma venere or infections caused by the human papillomavirus).
Infections related to health care, with special emphasis on those difficult to treat (cardiovascular infections or infections related to prosthetic materials) or caused by multi-resistant pathogens (MDRO) or affecting vulnerable populations.
Global Health and Tropical Diseases with special emphasis on prevalent diseases in our environment that affect the immigrant or displaced population.
PMID: 32979154 Journal: INFECTION Year: 2021 Reference: Infection. 2021 Apr;49(2):215-231. doi: 10.1007/s15010-020-01521-5. Epub 2020 Sep 26. Impact factor: 3.553 Publication type: Review in international publication Authors: Los-Arcos, Ibai, Alsina-Manrique, Laia, Diaz de Heredia, Cristina, Fortuny-Guasch, Claudia, Garcia-Cadenas, Irene, Garcia-Vidal, Carolina, Gonzalez-Vicent, Marta, Hernani, Rafael, Kwon, Mi, Machado, Marina et al. DOI: 10.1007/s15010-020-01521-5
PMID: 33010054 Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY Year: 2021 Reference: Br J Clin Pharmacol. 2021 Apr;87(4):2140-2145. doi: 10.1111/bcp.14582. Epub 2020 Nov 3. Impact factor: 4.34 Publication type: Paper in international publication Authors: Pigrau, Carles, Danes, Immaculada, Perez, Eulalia, Sueiras, Maria, Aguilera, Cristina, Agusti, Antonia, Perello, Manel, Gracia, Rosa M et al. DOI: 10.1111/bcp.14582
PMID: 33753569 Journal: Journal for ImmunoTherapy of Cancer Year: 2021 Reference: J Immunother Cancer. 2021 Mar;9(3). pii: jitc-2020-002277. doi: 10.1136/jitc-2020-002277. Impact factor: 13.751 Publication type: Paper in international publication Authors: Cruz, Claudia Andrea, Biello, Federica, Generali, Daniele, Grisanti, Salvatore, Seeva, Pavetha, Rizzo, Gianpiero, Libertini, Michela, Maconi, Antonio, Moss, Charlotte, Russell, Beth et al. DOI: 10.1136/jitc-2020-002277
PMID: 33367806 Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY Year: 2021 Reference: J Antimicrob Chemother. 2021 Mar 12;76(4):930-935. doi: 10.1093/jac/dkaa536. Impact factor: 5.79 Publication type: Paper in international publication Authors: Pumarola, T, Hoyos-Mallecot, Y, Serra-Pladevall, J, Gonzalez-Lopez, J J, Arando, M, Barbera, M J, Cornejo-Sanchez, T, Salmeron, P, Moreno-Mingorance, A, Trejo, J et al. DOI: 10.1093/jac/dkaa536
PMID: 32127121 Journal: Eurosurveillance Year: 2020 Reference: Euro Surveill. 2020 Feb;25(8). doi: 10.2807/1560-7917.ES.2020.25.8.1900393. Impact factor: 6.454 Publication type: Paper in international publication Authors: Velasco, Maria, Gimeno-Feliu, Luis Andres, Molina, Israel, Salas-Coronas, Joaquin, Sola, Ivan, Monge-Maillo, Begona, Torrus-Tendero, Diego, Cayla, Joan, de Guzman, Ena Nino, Arellano, Jl Perez et al. DOI: 10.2807/1560-7917.ES.2020.25.8.1900393
PMID: 31821494 Journal: JOURNAL OF TRAVEL MEDICINE Year: 2020 Reference: J Travel Med. 2020 Feb 3;27(1). pii: 5671715. doi: 10.1093/jtm/taz099. Impact factor: 7.089 Publication type: Paper in international publication Authors: Mendoza-Palomar, Natalia, Sulleiro, Elena, Perez-Garcia, Irene, Espiau, Maria, Soriano-Arandes, Antoni, Martin-Nalda, Andrea, Espasa, Mateu, Zarzuela, Francesc, Soler-Palacin, Pere et al. DOI: 10.1093/jtm/taz099
PMID: 31771856 Journal: MEDICINA CLINICA Year: 2020 Reference: Med Clin (Barc). 2020 Feb 14;154(3):101-107. doi: 10.1016/j.medcli.2019.07.026. Epub 2019 Nov 23. Impact factor: 1.635 Publication type: Review in national publication Authors: Ruiz-Camps, Isabel, Aguilar-Company, Juan, Los-Arcos, Ibai et al. DOI: 10.1016/j.medcli.2019.07.026
PMID: 31767220 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2020 Reference: Enferm Infecc Microbiol Clin. 2020 Jan;38(1):1-3. doi: 10.1016/j.eimc.2019.10.002. Epub 2019 Nov 22. Impact factor: 1.654 Publication type: Editorial in national publication Authors: Ruiz Camps, Isabel et al. DOI: 10.1016/j.eimc.2019.10.002
PMID: 30865352 Journal: Transplant Infectious Disease Year: 2019 Reference: Transpl Infect Dis. 2019 Jun;21(3):e13072. doi: 10.1111/tid.13072. Epub 2019 Mar 27. Impact factor: 2.112 Publication type: Review in international publication Authors: Los-Arcos, Ibai, Royuela, Meritxell, Martin-Gomez, Maria Teresa, Alastruey-Izquierdo, Ana, Sellares, Joana, Perello, Manel, Castells, Lluis, Dopazo, Cristina, Gavalda, Joan, Len, Oscar et al. DOI: 10.1111/tid.13072
PMID: 30862335 Journal: Eurosurveillance Year: 2019 Reference: Euro Surveill. 2019 Mar;24(10). doi: 10.2807/1560-7917.ES.2019.24.10.1900146. Impact factor: 7.421 Publication type: Paper in international publication Authors: Johnston, Victoria, Cotar, Ioana Ani, Popescu, Corneliu, Hamer, Davidson H, Gautret, Philippe, Eldin, Carole, Pietroski, Nancy, Field, Vanessa, Molina, Israel, Javelle, Emilie et al. DOI: 10.2807/1560-7917.ES.2019.24.10.1900146
PMID: 30860995 Journal: PLoS Neglected Tropical Diseases Year: 2019 Reference: PLoS Negl Trop Dis. 2019 Mar 12;13(3):e0007230. doi: 10.1371/journal.pntd.0007230. eCollection 2019 Mar. Impact factor: 4.487 Publication type: Review in international publication Authors: Barroso, Maria, Salvador, Fernando, Sanchez-Montalva, Adrian, Bosch-Nicolau, Pau, Molina, Israel et al. DOI: 10.1371/journal.pntd.0007230
PMID: 30845683 Journal: Nanomaterials Year: 2019 Reference: Nanomaterials (Basel). 2019 Mar 6;9(3). pii: nano9030380. doi: 10.3390/nano9030380. Impact factor: 4.034 Publication type: Paper in international publication Authors: Rafael, Diana, Andrade, Fernanda, Martinez-Trucharte, Francesc, Basas, Jana, Seras-Franzoso, Joaquin, Palau, Marta, Gomis, Xavier, Perez-Burgos, Marc, Blanco, Alberto, Lopez-Fernandez, Alba et al. DOI: 10.3390/nano9030380
The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues.
